Zamagni, E., Facon, T., Dimopoulos, M. A., Leleu, X. P., Beksac, M., Pour, L., Hajek, R., Liu, Z., Minarik, J., Moreau, P., Romejko-Jarosińska, J., Špička, I., Martin, T. G., Qiu, L., Sachpekidis, C., Kodas, E., Velde, H. V. D., Zhao, L., Orlowski, R., Goldschmidt, H. (2025). Positron emission tomography with computed tomography (PET/CT) and minimal residual disease (MRD) for efficacy assessment in transplant-ineligible newly diagnosed myeloma (Ti NDMM) patients (pts): IMROZ analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7551